|

|
Kendle International Inc.
Doug Moehring
441 Vine Street, Suite 1200
Cincinnati, OH 45202 USA
Phone: 513-381-5550 ; 800-733-1572 (in US only)
Fax: 513-381-5870
E-mail:
Web: http://www.kendle.com
 Provided by MapQuest
|
|
Company Overview
Kendle International Inc. (Nasdaq: KNDL) is among the world’s
leading global clinical research organizations and is the
fourth-largest provider of Phase II-IV clinical development
services. We deliver innovative and robust clinical development
solutions -- from first-in-human studies through market launch and
surveillance -- to help the world’s biopharmaceutical companies
maximize product life cycles and grow market share. Our global
clinical development business is focused on five regions -- North
America, Europe, Asia/Pacific, Latin America and Africa -- to meet
customer needs. With the expertise of more than 3,000 associates
worldwide, Kendle has conducted clinical trials or provided
regulatory and pharmacovigilance/safety services in more than 80
countries.
The company was named the "Top CRO to Work With" in
the Thomson CenterWatch 2007 Survey of U.S. Investigative
Sites.
Core Competencies
Clinical Development
Leveraging world-class therapeutic expertise and global patient
access capabilities
- Phase I -III Clinical Trials
- Project Planning/Management
- Patient Recruitment/Study Feasibility
- Clinical Monitoring
- Investigator Recruitment and Site Selection
- Clinical Support Center
- Clinical Resourcing Clinical Pharmacology (Phase I/IIa
studies)
- Bioequivalence/Bioavailability/Pharmacokinetic
Studies
Regulatory Affairs
Guiding customers through the complex regulatory environment
- Strategic Clinical Development Planning
- Regulatory Submissions
- Clinical Trial Regulatory Affairs
- Nonclinical Consulting
- CMC Development
- Established Drug Substances
- Biological and Biotechnical Products
- Regulatory Affairs for Devices
- Pharmacovigilance/ Safety
Biometrics
Improving accuracy and increasing speed to market
- Clinical Data Management
- Biostatistics
- Clinical (EDC) services
Late Phase
Proactive/innovative approach to study design and execution;
value-added pre- and post-launch services to leverage results
- Phase IIIB/IV Study Design and Conduct
- Health Economics and Outcomes Research
- Product/Disease Registries
- Observational Studies
- Scientific Events, Education and Publications
services
For More Information
For more information and a proposal on your next project, please
contact Doug Moehring at 1-800-733-1572, ext. 1423 (outside of the
U.S. dial: +1-513-381-5550), or by e-mail at
moehring.doug@kendle.com
To view Kendle careers and our online application, go to
www.kendle.com and choose
"career opportunities."
|
 |
 Back to
Profiles of Industry Providers
 Click here to access this Center's WWW home page.
|